CE Marked                                                      

For In Vitro Diagnostic Use

Accurate quantitation of the Epstein-Barr Virus (EBV) is critical to the monitoring of post-transplant lymphoproliferative disease (PTLD) in immunocompromised graft recipients.  The Abbott RealTime EBV assay provides precise, reliable viral load results for supporting clinical management decisions.

The Abbott RealTime EBV assay has a low limit of quantification (corresponding to high sensitivity), which is helpful in transplant patients. 

Leading Science

  • Targets a highly conserved region of the BLLF1 gene Traceable to the first WHO International
  • Standard for EBV Nucleic Acid Amplification Techniques (NIBSC code: 09/260)
  • Whole blood and plasma sample types

Enabling Solutions

  • Flexible batch sizes: up to 24, 48, 72, or 96 samples enables greater efficiency and faster result reporting
  • Extensive m2000 System test menu for infectious disease allows for platform consolidation
  • Proven reliability of the m2000 System combined with multiple validity checks contributes to confidence in reported results
  • Sample preparation, amplification, and detection on the m2000 System

Precision and Efficiency

  • Automated sample extraction and master mix preparation reduces hands-on time
  • mPlus amplification reagent reuse provides processing flexibility